Say hi to Judi from AG Mednet!👋 Judi is the proven collaboration platform for #clinicaltrials that enables clinical teams around the world to come together to seamlessly manage complex workflows in endpoint adjudication, eligibility, data safety monitoring, medical imaging, and other mission-critical areas of clinical development. Schedule a demo today. Judi.io
Judi by AG Mednet, Inc.
Biotechnology Research
Boston, MA 4,898 followers
Welcome to the clinical trials revolution
About us
Judi by AG Mednet empowers the doers, clinical trial leaders, and medical innovators, with streamlined process management software, allowing them to focus on what they do best, providing breakthrough treatments and products. We remove unnecessary cost and effort, introducing greater control, enabling transparency, and allowing seamless collaboration, which speeds the time to market.
- Website
-
http://www.judi.io
External link for Judi by AG Mednet, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Boston, MA
- Type
- Privately Held
- Founded
- 2004
- Specialties
- DICOM De-identification, Pixel De-Identification, Clinical Trial Data Storage, Clinical Trial Submission Management Portal, Electronic Endpoint Adjudication, Pharmaceuticals, Life Sciences, Medical Devices, Clinical Trials, Medical Imaging, and pharmacovigilance
Locations
-
Primary
2 Atlantic Ave.
Boston, MA 02110, US
Employees at Judi by AG Mednet, Inc.
-
Josue Franco
Software Support Leader with experience building and mentoring award-winning teams that guarantee customers' success.
-
David Lichtman
Head of Commercial Operations at AG Mednet, Inc.
-
Matt Cocking
Global Head of Business Development & Marketing @ AG Mednet, Inc.
-
Don Wright
Working with Sponsors, CROs, Sites and Core Labs, helping them collaborate for faster, better clinical outcomes.
Updates
-
Interius BioTherapeutics has received Australian approval to start a Phase I trial testing INT2104, an innovative CAR-T #oncology therapy. Scheduled for the last quarter of this year, the trial aims to assess the safety of a single dose of INT2104 in adults with recurrent B-cell malignancies. At AG Mednet, we're dedicated to advancing #innovation and streamlining #clinicaltrials, so vital new therapies reach patients, faster. In recent years, our Judi collaboration platform has supported over 720 oncology trials, including pioneering CAR-T #research. Judi.io
-
Congratulations to our many clients and partners on Time's Most Sustainable Companies of 2024. At AG Mednet, #sustainability is a core value. Our purpose-built Judi collaboration platform provides robust simplicity, and streamlined #clinicaltrials workflows, which eliminates unnecessary travel and expense, so vital new therapies reach patients, faster. Judi.io
World’s Most Sustainable Companies of 2024
time.com
-
GlobalData Healthcare considers the growth of chimeric antigen receptor (CAR)-T therapy, a type of #immunotherapy that modifies patient's T-cells to destroy cancer. On our Insights page, read how a prominent biotech employed Judi for Eligibility and Judi for Adjudication on a pivotal Phase 2 CAR-T #oncology #clinicaltrial. Judi.io
CAR-T landscape set to expand in 2024
clinicaltrialsarena.com
-
Applied Clinical Trials reports on the FDA's proposed guidance for improving #diversity in #clinicaltrials. This pioneering guidance emerged through a collaborative effort involving the #Oncology Center of Excellence Project Equity, alongside the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Health, the Office of Women’s Health, and the Office of Minority Health and Health Equity. The selection of appropriate participants is crucial for the success of any study. With Judi, achieving this is optimized, ensuring the efficiency and success of your trials every single time. Judi.io
FDA Issues Draft Guidance on the Submission of Diversity Action Plans
appliedclinicaltrialsonline.com
-
This article explores an intriguing pilot initiative that shines a spotlight on sustainable supply chains within the #clinicaltrials sector. At AG Mednet, we prioritize innovation and comprehensive accountability, seamlessly integrating these principles into our Judi collaboration platform.
Pivoting Toward Sustainable Supply Chains in Clinical Research
appliedclinicaltrialsonline.com
-
Discover the reasons behind the choice of Judi for DSMB in a Phase 2 #clinicaltrial by an international biopharma sponsor and their collaborative CRO partner. Uncover the factors that set Judi apart in the realm of clinical trial oversight and data safety monitoring, ensuring the highest standards of efficacy and safety are met. Click below to learn how Judi is revolutionizing clinical trial management. 👇
International biopharma sponsor and partner CRO maximize flexibility of Judi for DSMB for Phase 2 multinational clinical program
judi.io
-
This thought-provoking discussion delves into #sustainability and highlights how advanced #clinicaltrials technology, such as AG Mednet's Judi collaboration platform, plays a crucial role in ensuring that vital therapies reach underrepresented populations. Judi.io
Very excited to share the abridged transcript of a recent roundtable I convened on sustainability in clinical trials! Our participants—Cedric Burg, Dave Hanaman, Ingrid Oakley-Girvan, PhD, MPH, Bryan C. Spielman, Bill Sterling, and Julia Sundari—discussed a variety of topics including industry's carbon footprint, the use of technology, reaching underrepresented populations, and more! The article is featured in our June issue of Applied Clinical Trials Magazine. Check it out!
Status Check: Science & Sustainability
appliedclinicaltrialsonline.com
-
We’re #hiring a new Project Coordinator! Join the team optimizing #clinicaltrials workflows, so vital new therapies reach patients, faster. Apply today or share this post with your network.
-
Excited to join the inaugural #CRO Summit this December, in Raleigh, NC, bringing together #clinicaltrial industry leaders for a dynamic and motivating program.
🎅 🎄 Can you hear the sleigh bells? Early December the PBC Group - Organisers of the COG Series, host our inaugural CRO Summit in Raleigh, North Carolina. Held on the 3rd & 4th December, at the Raleigh Marriott City Center. The program focuses on delivering unique takeaways for the US & Europe's vast #CRO community across the below key themes: 🤝 Collaboration: Fostering effective collaboration between sponsors, CROs, and vendors to optimize trial delivery and outcomes. 💾 Technology Integration: Leveraging cutting-edge technologies, such as digitalization, data-driven insights, and AI, to revolutionize clinical trials. 🌠 Vendor Alliances: Exploring strategies for CROs to forge strategic alliances with Functional Service Providers (FSPs) and technology vendors to gain a competitive edge in winning bids. 💰 Budgeting and Forecasting: Mastering budget management, innovative contracting, and financial forecasting for clinical trial profitability and transparency. 🏥 Site Relationships: Enabling site success through collaboration, technology, and upskilling to optimize performance in complex trials, including cell and gene therapies. 🧠 Artificial Intelligence: Harnessing AI and Large Language Models (LLMs) to streamline processes, accelerate studies, and bridge the technology gap with non-tech savvy partners. 👩👦👦 Patient Engagement: Embracing diversity, inclusion, and innovative strategies to engage and recruit patients, particularly in rare and orphan disease trials. The first of it's kind, the CRO Summit brings together operational CRO industry leaders to discuss the latest trends, challenges, and opportunities in the global #clinicaldevelopment landscape. Confirmed CRO Summit Partners: Judi by AG Mednet, Inc., Endpoint Clinical, Florence Healthcare, HeartcoR Solutions, LLC, Mednet, Prevail InfoWorks, SDC (Statistics & Data Corporation), TrialStat Solutions Inc., Medidata Solutions, Monitorforhire.com, BioBridges This week the COG Series advisory board will be reviewing the draft program, if you'd like a sneak-peak whilst we are going through quality-control, reach out to me directly at djo@thepbcgroup.com Advisory Board: Phill Gallacher, Dana Niedzielska, Joan Chambers, Lisa Chamberlain James, Bornadata (Bonnie) Bain, Ph.D., Andy Thurstan & Helen Blanco